Well yes they do have a legal responsibility, here are some guidelines:
It needs to be done if its appropriate and there are no other viable official alternatives etc.
Weighing up of cost/benefit analysis is also a consideration to the patient etc.
Sure some Docs wouldn't be prepared to do it...but it is allowed in light of the above points and considerations.
Check out below references for additional info.
REFERENCES
1) https://www.mdanational.com.au/advice-and-support/library/articles-and-case-studies/2019/11/off-label-prescribing-what-you-need-to-know#:~:text=In%20summary,exhausted%2C%20not%20tolerated%20or%20unsuitable.
2) https://www.anzca.edu.au/resources/professional-documents/guidelines/use-of-off-label-or-drugs-beyond-licence-in-pain-m
- Forums
- ASX - By Stock
- PAR
- PAR, some place in QLD and the (magical) possible pathway...
PAR, some place in QLD and the (magical) possible pathway..., page-23
- There are more pages in this discussion • 24 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PAR (ASX) to my watchlist
(20min delay)
|
|||||
Last
23.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $82.20M |
Open | High | Low | Value | Volume |
23.5¢ | 24.0¢ | 23.0¢ | $125.0K | 528.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 92561 | 23.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
24.0¢ | 135545 | 9 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 92561 | 0.235 |
12 | 103838 | 0.230 |
3 | 14310 | 0.225 |
7 | 177664 | 0.220 |
3 | 66705 | 0.215 |
Price($) | Vol. | No. |
---|---|---|
0.240 | 135545 | 9 |
0.245 | 97590 | 6 |
0.250 | 62268 | 4 |
0.255 | 65703 | 6 |
0.260 | 122632 | 8 |
Last trade - 15.46pm 17/06/2024 (20 minute delay) ? |
|
|||||
Last
23.5¢ |
  |
Change
0.000 ( 0.00 %) |
|||
Open | High | Low | Volume | ||
24.0¢ | 24.0¢ | 23.5¢ | 80791 | ||
Last updated 15.54pm 17/06/2024 ? |
Featured News
PAR (ASX) Chart |
The Watchlist
LPM
LITHIUM PLUS MINERALS LTD.
Simon Kidston, Non Executive Director
Simon Kidston
Non Executive Director
SPONSORED BY The Market Online